Latest Opdivo news
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients
posted November 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
posted September 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
AACR: Adding Nivolumab to Neoadjuvant Chemo Slows Resectable NSCLC
posted April 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Human Respiratory System Anatomy
Gene Mutation Identified That Increases Lung Cancer Risk 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Cancer Drug Shortages Persist at All Cancer Centers 
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma 
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance 
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma 
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma Monthly Specialist Briefings
Stay Connected
